Eton Pharmaceuticals Stock Forecast
NASDAQ: ETONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 54.75 0.00%
ETON analyst consensus
Consensus (4 analysts)
strong_buy
Avg. price target
$71.00+29.68%
- Strong buy 0
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 4 Wall Street analysts covering Eton Pharmaceuticals (2026-10-08), 4 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $71.00, with a high estimate of $76.00 and a low estimate of $68.00. The average target implies upside of 29.7% from the current price of $54.75.
The spread between the highest and lowest targets is 11.8%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ETON.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 4 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $68.00 | +24.20% |
| Average target | $71.00 | +29.68% |
| High target | $76.00 | +38.81% |